ABD’de yetişkinlerde bağışıklık arttırmaya yönelik rehber (İng)
Recommended Adult Immunization Schedule for 2013
Highlights of the updated recommendations and a link to the CDC’s vaccine resources
The U.S. Advisory Committee on Immunization Practices has issued updated guidelines for adult immunization. Highlights include the following:
- 13-valent pneumococcal conjugate vaccine (PCV13) is recommended for adults (age, 19) with immunocompromising conditions (in addition to the pneumococcal polysaccharide vaccine, or PPSV23).
- PPSV23 should be administered to elders (age, 65) and readministered to those who received one or two doses before age 65 if at least 5 years have passed.
- Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination is recommended for elders (age, 65) and for pregnant women (at 27–36 weeks’ gestation) to help protect newborns.
- Live attenuated influenza vaccine (LAIV) for the 2013–2014 season likely will be available only as a quadrivalent vaccine (including 2 influenza A strains, H3N2 and H1N1, and 2 influenza B strains), which is expected to improve coverage beyond that of the previous trivalent vaccine.
- Patients who experience only hives from egg exposure should receive inactivated influenza vaccine (IIV) rather than LAIV. IIV might be available in both the trivalent and quadrivalent forms for 2013–2014.
- Bivalent human papillomavirus vaccine (HPV2) or quadrivalent vaccine (HPV4) are recommended for girls and women, and HPV4 is recommended for boys and men.
Comment: Levels of vaccination adherence remain low, and a strong recommendation from providers is associated with better adherence. The CDC website is an excellent resource for all vaccine-related issues